Microsomal Transfer Protein Inhibitors, New Approach for Treatment of Familial Hypercholesterolemia, Review of the Literature, Original Findings, and Clinical Significance

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-5922|33|2|71-78

ISSN： 1755-5914

Source： CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.2, 2015-04, pp. : 71-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein apheresis for the treatment of familial hypercholesterolemia

By Walji Shahenaz   Neuwirth Clare   Thompson Gilbert R  

Clinical Lipidology, Vol. 8, Iss. 5, 2013-10 ,pp. : 573-586

Future Medicine

Access to resources Recommend Favorite

Liver transplantation as a definitive treatment for familial hypercholesterolemia: A series of 36 cases

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 605-611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stroke patients with familial hypercholesterolemia: need for detection and aggressive treatment

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : 211-212

John Wiley & Sons Inc

Access to resources Recommend Favorite

Homozygous familial hypercholesterolemia

By Wierzbicki Anthony S  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 407-409

Future Medicine

Access to resources Recommend Favorite

An Ergot Alkaloid Preparation (Hydergine) in the Treatment of Dementia: Critical Review of the Clinical Literature

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 11, 1976-11 ,pp. : 490-497

John Wiley & Sons Inc

Access to resources Recommend Favorite